Gabriele Guido, Nigri Andrea, Chisci Glauco, Massarelli Olindo, Cascino Flavia, Komorowska-Timek Ewa, Kazuki Kikuchi, Hara Hisako, Mihara Makoto, Gennaro Paolo
Department of Maxillo-Facial Surgery, Faculty of Medicine and Surgery, University of Siena, 53100 Siena, Italy.
Department of Economics, Management and Territory, University of Foggia, 71122 Foggia, Italy.
J Clin Med. 2024 May 13;13(10):2872. doi: 10.3390/jcm13102872.
Cancer-related lymphedema represents a potential complication of cancer treatment. The aim of this study is to evaluate the effectiveness of the combination of lymphatico-venular anastomosis and liposuction in the treatment of secondary lymphedema. We present a retrospective analysis of patients affected by cancer-related unilateral limb lymphedema. Inclusion criteria included previous neoplastic pathology with the consequent development of unilateral limb lymphedema, while the exclusion criteria included the presence of comorbidities and the persistence of cancer, as well as previous lymphatic surgery. The outcomes to be included were a reduction in the limb volume and lymphangitis rate, and an improvement in the quality of life. Patients' data were assessed before surgery and 1 year after surgery. Perioperative management included clinical and ultrasonographical evaluations. Under local anesthesia, lymphatico-venular anastomosis with the supramicrosurgical technique and the liposuction of the affected limb was performed in the same surgical session. A total of 24 patients were enrolled in the study. One year after the surgery, an average volume reduction of 37.9% was registered ( = 0.0000000596). The lymphangitis rate decreased after surgery from 4.67 to 0.95 per year ( = 0.000007899). The quality-of-life score improved from 68.7 to 16 according to the LLIS scale. The combination of LVA and liposuction represents a valid strategy for treating cancer-related lymphedema, ensuring stable results over time. In addition, it can be performed under local anesthesia, resulting in being minimally invasive and well-tolerated by patients. This paper reports on the short-term efficacy of this combined technique.
癌症相关淋巴水肿是癌症治疗的一种潜在并发症。本研究旨在评估淋巴管静脉吻合术与抽脂术联合治疗继发性淋巴水肿的有效性。我们对患有癌症相关单侧肢体淋巴水肿的患者进行了回顾性分析。纳入标准包括既往有肿瘤病史并随之出现单侧肢体淋巴水肿,而排除标准包括存在合并症、癌症持续存在以及既往有淋巴手术史。纳入的观察指标包括肢体体积减小、淋巴管炎发生率降低以及生活质量改善。在手术前和术后1年对患者数据进行评估。围手术期管理包括临床和超声评估。在局部麻醉下,于同一手术过程中采用超显微外科技术进行淋巴管静脉吻合术,并对患侧肢体进行抽脂。共有24例患者纳入本研究。术后1年,平均体积减小37.9%(P = 0.0000000596)。淋巴管炎发生率从术前每年4.67次降至术后每年0.95次(P = 0.000007899)。根据LLIS量表,生活质量评分从68.7提高到了16。淋巴管静脉吻合术与抽脂术联合是治疗癌症相关淋巴水肿的一种有效策略,可确保长期稳定疗效。此外,该手术可在局部麻醉下进行,具有微创性且患者耐受性良好。本文报道了这种联合技术的短期疗效。